Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HFR-SUPRA in Multiple Myeloma-related Acute Kidney Injury
NCT05429515Phase 4Not yet recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jul 2022
- Primary completion
- Jul 2032
01
Overview
Phase 4, open-label trial (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Independence from dialysis at 90 days. Planned start Jul 2022; status: not yet recruiting.
Beyond the preview
Go deeper on NCT05429515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05429515.